Process and methods
Evidence summaries are correct at the time of publication and are not routinely reviewed and updated. The date of publication is stated, with a reminder to consult the British National Formulary and summary of product characteristics for up-to-date information on the topic.
They may be updated in exceptional circumstances, such as:
if the evidence base is changing quickly and this affects the place in therapy
at the request of the organisation commissioning the topic, if evidence is identified that may mean changing a commissioning policy.
Sometimes an evidence summary may be withdrawn, for example:
if NICE technology appraisal guidance or a NICE guideline on the topic is published
if an unlicensed or off-label indication reviewed in an evidence summary is granted a marketing authorisation. The medicine will then be considered as a potential topic for NICE technology appraisal guidance in line with those processes.